Skip to Main Content

Paper Details

Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Clin Cancer Res
0
2023
EWS, Ewing Sarcoma, Ewing sarcoma, Patients, ZOL, Zoledronic acid, patients, renal toxicities, tumor, tumors
Author NameAffiliation
Ruth LadensteinSt. Anna Children's Hospital and Children's Cancer Research Institute (CCRI), Medical University
Stefan BurdachTechnische Universitat Munchen
Stefan BurdachTechnische Universitat Munchen
Marie BernkopfChildren's Cancer Research Institute
Markus MetzlerUniversity Hospital Erlangen
Uta DirksenUniversity Hospital Essen, West German Cancer Center
Uta DirksenUniversity Hospital Essen, West German Cancer Center
  • 1 - 7

Datasets

Release 1.2